Algernon Pharmaceuticals Inc. C.AGN

Ifenprodil - cytokine storm - same as phase 1 israel co.

[Heinrich2]

Ifenprodil fights the cytokine storm — a potentially lethal immune overreaction to the coronavirus infection that is believed to be responsible for much of the deaths associated with the disease. This is what AGNPF does, the Israel drug has just completed phase 1, and we are already finishing 2a and going into phase 3.

Details Here : https://www.timesofisrael.com/new-israeli-drug-cured-moderate-to-serious-covid-cases-within-days-hospital/
Another doctor saying good things : Key portion of the article.... But there is hope. Westchester is among a few hospitals around the world studying a new drug.

https://wsvn.com/news/special-reports/breath-of-hope-south-florida-doctors-lead-way-against-treating-severe-lung-damage-caused-by-covid-19/

Dr. Jose Suarez: “So we’re doing a trial with Algernon, a medication called Ifenprodil, which has been around since the ’70s, and we’re starting to use it on COVID patients, and it’s a potent anti-inflammatory.” It’s hoped the drug will reduce the scarring of lung tissue which has led to so many long term problems.

Right now, it’s only being used on critically ill patients, and Dr. Suarez says the results are looking good.
Dr. Jose Suarez: “These patients are not getting that scarring that we usually see with the COVID patients, and their reactions to the treatment is phenomenal.”
Dr. Suarez says 10 patients who have received the drug have recovered from COVID without the scarring, and he believes studies like this one provide hope for future COVID patients.